iShares Biotechnology ETF

Think of an ETF as a 'basket' of different assets—such as stocks, bonds, or gold. Instead of buying each item individually, you buy one share of the basket. This gives you instant diversification with the added benefit of being able to trade it instantly during market hours.

IBB price decreased by -1.62% on the last trading day 10 Apr 2026, falling from 172.16 USD to 169.37 USD. Throughout the last trading session, the ETF experienced a fluctuation of 2.83%, ranging from a day low of 168.56 USD to a day high of 173.44 USD. The price has -- in -- of the last 10 days, resulting in a total change of 0.08% during this period.

IBB price has risen by 2.33% over the last month, and its yearly performance shows a 44.81% risen. NAV returns, another gauge of an ETF dynamics, The YTD NAV total return reached 0.30%.The 1-year NAV total return amounted to 45.20%.The 3-year NAV total return totaled 30.65%.

As of Apr, 10 2026, The 1-month fund flow of IBB recorded a decrease of -26.28M USD, while the 3-month and YTD figures stand at -195.30M USD and -105.64M USD respectively.

IBB expense ratio is 0.44%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.

No, IBB isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.

As of Apr, 10 2026, IBB manages 8.21B USD in assets with an expense ratio of 0.44%. It is a Core play for investors targeting GILD, and IBB tracks the NYSE Biotechnology Index. The current P/E is 17.01, and P/B is 4.37.

IBB currently offers a dividend yield of 0.23%, paying out 0.39 USD annually per share. The Dividend Frequency is Quarterly. This structured payout schedule ensures that the fund's earnings are consolidated and distributed to shareholders Quarterly.

IBB last dividends amounted to 0.12 USD . The Quarterly before, the issuer paid 0.18 USD in dividends, which shows a -33.47% decrease.